MedPath

Effect of dapagliflozin on blood pressure, cardiac function, visceral fat in type 2 diabetes mellitus patients with hypertension.

Not Applicable
Conditions
type 2 diabetes
Registration Number
JPRN-UMIN000015203
Lead Sponsor
Takeda Hospital Medical Examination Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients who are Type I or Secondary diabetic mellitus 2) Patients who are treating with Insulin theraphy at the time of study initiation 3) Patients who are severe infectious disease, perioperative, and severe trauma 4)Patients who are pregnant, lactating, and possibly pregnant women and those planning to become pregnant 5)Patients with myocardial infarction, angina pectoris, cerebral stroke, or cerebral infarction before 3 month 6) patients with Arrhythmia,atrial fibrillation 7) Patients with a history of hypersensitivity to investigational drugs 8) Patients with cancer 9) Patients who receive steroid therapy with inflammatory affection 10) Patients whom doctor judges as ineligible to this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath